跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,246 条关于
“HL192 (ATH-399A)”
全部
4,246
临床试验
1,889
药物
436
机构
76
资讯
1,845
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
HanAll Biopharma Announces Q3 2024 Results, Highlights Progress in Autoimmune and Neurology Programs
去年
Alterity Therapeutics' ATH-434 Shows Promise in Slowing Multiple System Atrophy
3个月前
LeonaBio Unveils Phase 2 Plans for Brelgometon (ATH-1105) in ALS, Highlighting Biomarker-Driven Trial Design at Summit
11个月前
Predictive Oncology Secures $343.5 Million to Launch World's First Strategic Compute Reserve for AI Drug Discovery
去年
Athira Pharma Presents LIFT-AD Trial Results for Fosgonimeton at CTAD 2024
10个月前
Athos Therapeutics Partners with Xeptiva to Deploy AI Platform for Veterinary Vaccine Biomarker Discovery
6个月前
Cosmos Health Strengthens AI Drug Discovery Platform with Appointment of Athos Therapeutics CEO Dr. Dimitrios Iliopoulos
2年前
Athira Pharma's Fosgonimeton Fails to Meet Primary Endpoint in Phase II/III Alzheimer's Trial
11个月前
Propanc Biopharma Secures $100 Million Financing to Advance Cancer Stem Cell Therapy PRP Toward First-in-Human Trial
第 1 页,共 185 页
上一页
下一页